As an example, osteoblast and osteocyte-released RANKL promotes tumour progression both directly, by stimulating proliferation of tumour cells through RANK, and indirectly, by promoting osteoclastogenesis, through the release of EV-bound RANKL [12,27]. This evidence concerns the gene TNFSF11 and neoplasm.